Target intelligence / Profile preview

UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 pseudogene

Molecular classification
Other (pseudogene)
01

Overview

This record refers to a pseudogene related to UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GALNT11), also known as polypeptide GalNAc transferase 11 or GalNAc-T11[5]. GALNT11 is part of a family of enzymes that catalyze the first step of O-linked glycosylation by transferring N-acetylgalactosamine to serine or threonine residues on polypeptides, an activity important for mucin-type glycoprotein biosynthesis[2][3][5][8]. However, as a **pseudogene**, ENSG00000224570 **does not encode a functional protein** and is considered non-functional; it is not a receptor, enzyme, or known therapeutic target[6][8]. Functional gene: **GALNT11** (not the pseudogene), has roles in **protein O-glycosylation** and possibly ciliary function and Notch signaling, but this does not apply to the pseudogene[1][5][6][8]. If your intent is to find information on the active, protein-coding gene and its enzyme product, the correct entry is GALNT11 (for which gene and protein-level data, alternate names, and potential functional and disease information are available)[1][5][6][8]. If you want structured data for the protein-coding version, clarify this in your query.

Other names
GalNAc-T11 pseudogenepolypeptide N-acetylgalactosaminyltransferase 11 pseudogene

Beyond the preview

Go deeper on UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call